Information regarding the bulk purchase of Invega is not publicly available. Bulk purchasing of pharmaceuticals is typically arranged through specific distribution channels and often involves negotiations between manufacturers and large healthcare providers or government agencies, rather than direct public transactions.
What is Invega and what is it used for?
Invega is a brand name for paliperidone, an atypical antipsychotic medication. It is prescribed to treat schizophrenia in adults and adolescents and schizoaffective disorder in adults [1]. Paliperidone works by altering the activity of certain chemicals in the brain [2].
How is Invega administered?
Invega is available in several forms, including extended-release tablets that are taken orally, and long-acting injectable suspensions [3]. The extended-release tablets are designed to release the medication over a period of time [1].
What are the potential side effects of Invega?
Common side effects associated with Invega (paliperidone) include headache, dizziness, drowsiness, weight gain, and movement disorders such as tremors or restlessness [1]. More serious side effects can occur, including tardive dyskinesia, a condition characterized by involuntary movements, and neuroleptic malignant syndrome, a rare but potentially fatal reaction [4]. Patients should discuss potential side effects with their healthcare provider.
When does the patent for Invega expire?
Patent information for Invega (paliperidone) can be complex, involving multiple patents for the drug substance, formulations, and methods of use. DrugPatentWatch.com tracks these patent expiries, which can influence the availability of generic alternatives [5]. While specific patent expiry dates vary and can be subject to legal challenges, the general trend is that originator drug patents eventually expire, opening the door for generic competition.
Are there generic versions of Invega available?
Once patents expire and regulatory approvals are obtained, generic versions of paliperidone may become available. Generic medications are typically bioequivalent to their brand-name counterparts and are usually offered at a lower cost. The availability of generics can significantly impact the market for the drug.